Dermatology Update 2018 FALL

SESSIONS & ABSTRACTS

MONTREAL, FAIRMONT THE QUEEN ELIZABETH - NOVEMBER 15-18, 2018

AbbVie Risankizumab Psoriasis Ad Board

AbbVie consistently strives to develop educational programs and initiatives of the highest quality in order to help physicians advance patient care through newly acquired knowledge. Through discussions and workshops, the Advisory Board members will provide advice concerning the design and content of AbbVie’s educational programs to ensure that it addresses educational gaps, adds value and is relevant for the Canadian dermatology community. The Advisory Board members will provide AbbVie with a better understanding of the psoriasis landscape and the challenges encountered by dermatologists in their learning journey.

LEARNING OBJECTIVES

  • Identify the challenges posed in your clinic with a new drug entry for the management of moderate-to-severe psoriasis
  • Discuss the rationale for a PPA (Psoriasis Practice Assessment) and how it may impact on better patient outcomes
  • Review and validate the PPA questionnaires in order to ensure that the set objectives are met and adds value to clinical practice
  • Evaluate and select key elements of a learning continuum in dermatology and more specifically in psoriasis

PART OF THE EVENT

Missing Event Data
Abbvie - Dermatology Update Sponsor